- Home
- CRIS vs DRCT Comparison
CRIS vs DRCT Comparison
Compare CRIS & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- DRCT
- Stock Information
- Founded
- CRIS 2000
- DRCT 2018
- Country
- CRIS United States
- DRCT United States
- Employees
- CRIS N/A
- DRCT N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- DRCT Computer Software: Programming Data Processing
- Sector
- CRIS Health Care
- DRCT Technology
- Exchange
- CRIS Nasdaq
- DRCT Nasdaq
- Market Cap
- CRIS 13.5M
- DRCT 16.7M
- IPO Year
- CRIS 2000
- DRCT 2022
- Fundamental
- Price
- CRIS $1.96
- DRCT $0.59
- Analyst Decision
- CRIS Strong Buy
- DRCT Strong Buy
- Analyst Count
- CRIS 3
- DRCT 1
- Target Price
- CRIS $21.00
- DRCT $6.00
- AVG Volume (30 Days)
- CRIS 99.1K
- DRCT 2.9M
- Earning Date
- CRIS 05-06-2025
- DRCT 05-06-2025
- Dividend Yield
- CRIS N/A
- DRCT N/A
- EPS Growth
- CRIS N/A
- DRCT N/A
- EPS
- CRIS N/A
- DRCT N/A
- Revenue
- CRIS $11,202,000.00
- DRCT $48,170,000.00
- Revenue This Year
- CRIS $4.67
- DRCT $53.01
- Revenue Next Year
- CRIS $9.77
- DRCT $11.11
- P/E Ratio
- CRIS N/A
- DRCT N/A
- Revenue Growth
- CRIS 14.17
- DRCT N/A
- 52 Week Low
- CRIS $1.02
- DRCT $0.44
- 52 Week High
- CRIS $16.93
- DRCT $6.59
- Technical
- Relative Strength Index (RSI)
- CRIS 50.58
- DRCT 43.05
- Support Level
- CRIS $1.85
- DRCT $0.81
- Resistance Level
- CRIS $2.25
- DRCT $1.23
- Average True Range (ATR)
- CRIS 0.27
- DRCT 0.13
- MACD
- CRIS 0.04
- DRCT -0.00
- Stochastic Oscillator
- CRIS 41.73
- DRCT 8.52
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.